January 08, 2025 04:48 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad

Centre asks drug manufacturers to increase production of amphotericin B to treat Black Fungus Disease

May 13, 2021, at 07:55 am

New Delhi/IBNS: The Central government has started working with the pharma companies producing amphotericin B to ramp up the production of anti-fungal medicine used in the treatment of mucormycosis, the “black fungus" infection being reported in some covid-19 patients across India.

Madhya Pradesh govt worried after 50 patients diagnosed with Black Fungal Disease

May 13, 2021, at 06:10 am

Bhopal/IBNS: Covid patients being infected with mucormycosis or "black fungal disease" have been increasing and fifty more infected patients in Madhya Pradesh have been diagnosed with the rare infection caused by a group of moulds called "mucormycetes" and affect people with weak immune systems.